Trials fall short on representation - Black patients underenrolled in MF/SS studies The February issue of JDD features a review of completed US interventional trials for mycosis fungoides and Sézary syndrome…
Read More
Case report shows dual IL‑17A/F blockade produced striking clinical and functional gains within one month in refractory ACH The February 2026 JDD issue features a case report about a 67‑year‑old…
Read More
Combined Relabotulinum Toxin A frontalis modulation with NASHA™ gel skinboosters for the temples yields natural‑looking wrinkle softening and lasting skin quality gains beyond six months The Oncoderm Resource Center on…
Read More
Medscape highlighted a January Journal of Drugs in Dermatology study on the incidence of skin and hair effects from GLP-1 agonists. The study, “Cutaneous Adverse Events Associated With GLP-1 Receptor…
Read More
Case report: six weeks of gentian violet and trichloroacetic acid peel produced marked healing in dominant dystrophic epidermolysis bullosa with minimal discomfort The February 2026 JDD issue features a case…
Read More
Combined Relabotulinum Toxin A frontalis modulation with NASHA™ gel skinboosters for the temples yields natural‑looking wrinkle softening and lasting skin quality gains beyond six months A preliminary clinical series tested…
Read More
From the Vault: Review of the last decade finds biological rationale for skin and hair benefits, yet no FDA approvals and major gaps in standardization and clinical data Dive into…
Read More
Curated by the JDD Editors Missed any of our January highlights? January is our Aesthetics issue and it’s packed with intriguing articles–start to dive in! Catch up with this curated…
Read More
Systematic review finds Astragalus membranaceus compounds offer photoprotection, collagen support and even telomere benefits, but larger trials are needed A PRISMA systematic review of studies from 2015-2025 highlights growing preclinical…
Read More
2024 Asia‑Pacific survey of 204 Thermage users finds ideal candidates in their 40s, rising confidence, common same‑day combos with injectables, and practical tips on tips, settings and safety InA 2024…
Read More
Case Report: Rare post‑booster pigment change - photodistributed hyperpigmentation reported after COVID‑19 vaccination Dive into one of JDD’s latest case reports ! A 70‑year‑old woman developed a diffuse blue‑grey, photodistributed…
Read More
From the Vault: Vitiligo trials lag on diversity - US studies underrepresent non‑White and Hispanic patients We are pulling this article from the JDD vault. It’s a July 2024 article…
Read More
